LMK Industri AB has granted Genovis SEK 600,000 as a contribution to the research project Sentinel node. The research grant is of great importance in the development of nanostructures that will be used for diagnosis (medical imaging) of very small tumors that can develop quickly in the lymph nodes of breast cancer patients.
In order to develop better drugs and more effective treatment for malignant diseases, we need more reliable diagnoses at an early stage, as well as better opportunities to follow up various therapies and medication dosages. The project is carried out in cooperation with the Department of Radiophysics at Lund University Hospital and is based on a brand new generation of nanoparticles having combined magnetic, radioactive and fluorescent properties for MRI/PET imaging. Genovis was earlier granted a position for an industry-based doctoral student by the Swedish Research Council for this project.
“In treatment of cancer, nanoparticles will be used as tools to facilitate treatment for both patients and doctors. Being able to work interdisciplinary in a project where nanoparticles have a crucial role is an excellent opportunity for Genovis. The project is still in an early phase, and the objective is to position the technique as a standard treatment method. The support and encouragement makes me very happy, and the grant strengthens the project”, says CEO Sarah Fredriksson.
Magnetic Resonance Imaging (MRI) is a biomedical imaging technique for diagnostic imaging with a scanner. The technique is used on patients to detect, locate and classify certain diseases and injuries that are hidden or difficult to see by x-ray or CT scan.
Positron emission tomography (PET) is a medical imaging technique based on the decay of radioactive isotopes and provides three-dimensional images of the movements of neurotransmitters in the body.
